Yumanity Therapeutics (YMTX) Financial Ratios Annual - Discounting Cash Flows
Yumanity Therapeutics, Inc.
YMTX (NASDAQ)

* (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
Price Ratios
Price to Earnings Ratio
Price to Sales Ratio
Price to Book Ratio
Price to Free Cash Flow Ratio
Price to Operating Cash Flow Ratio
Price Earnings to Growth Ratio
EV to EBITDA
Liquidity Ratios
Current Ratio
Quick Ratio
Cash Ratio
Debt Ratio
Debt to Equity Ratio
Long Term Debt to Capitalization
Total Debt to Capitalization
Interest Coverage Ratio
Cash Flow to Debt Ratio
Margins
Gross Profit Margin
Operating Profit Margin
Pretax Profit Margin
Net Profit Margin
Operating Cash Flow Margin
Free Cash Flow Margin
Return
Return on Assets
Return on Equity
Return on Capital Employed
Return on Invested Capital
Turnover Ratios
Receivables Turnover Ratio
Payables Turnover Ratio
Inventory Turnover Ratio
Fixed Asset Turnover Ratio
Asset Turnover Ratio
Per Share Items ()
Revenue Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
Cash & Short Term Investments
Earnings Per Share
EBITDA Per Share
Dividend Per Share
Enterprise Value Per Share
Price Per Share
Effective Tax Rate
Short Term Coverage Ratio
Capital Expenditure Coverage Ratio
EBIT Per Revenue
EBITDA Per Revenue
Days of Sales Outstanding
Days of Inventory Outstanding
Days of Payables Outstanding
Cash Conversion Cycle
Cash Conversion Ratio
Free Cash Flow to Earnings
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us